Poland· PL-100203585
Synflorix
A pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert product containing szczepionka przeciw pneumokokom, registered in Poland by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert is registered in 8 of 19 countries.
Countries holding a registration under ATC J07AL52 (pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert · ATC J07AL52
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka przeciw pneumokokom
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Country
- Poland (PL)
- ATC code
- J07AL52
- ATC class
- Pneumokokken, gereinigtes Polysaccharid-Antigen und Haemophilus influenzae B, konjugiert
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 9
- gtin05909990678099
- gtin05909990198214
- gtin05909990678068
- gtin05909990678075
- gtin05909990678082
- gtin05909990678105
- gtin05909990678112
- gtin05909990678129
- gtin05909990678136
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AL52
Pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert, as other registers publish it.
- BelgiumSynflorixGlaxoSmithKline Biologicals
- IcelandSynflorixGlaxoSmithKline Biologicals S.A.*
- DenmarkSynflorixGlaxoSmithKline Biologicals S.A.
- BelgiumSynflorixGlaxoSmithKline Biologicals
- FinlandSynflorixGlaxoSmithKline Biologicals SA
- FinlandSynflorixGlaxoSmithKline Biologicals SA
- BelgiumSynflorixGlaxoSmithKline Biologicals
- BelgiumSynflorixGlaxoSmithKline Biologicals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f15efba5-909c-4d55-a7be-b6e84e34c24e GET /v1/drugs/f15efba5-909c-4d55-a7be-b6e84e34c24e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina do wstrzykiwań",
"source": "urpl",
"strength": null,
"packaging": "05909990678099 ¦ Rp ¦ EU/1/09/508/005 ¦ 47791\n1 amp.-strzyk. 0,5 ml ¦ 2 igły \n05909990198214 ¦ Rp ¦ EU/1/09/508/001 ¦ 47893\n1 amp.-strzyk. 0,5 ml\n05909990678068 ¦ Rp ¦ EU/1/09/508/002 ¦ 47894\n10 amp.-strzyk. 0,5 ml\n05909990678075 ¦ Rp ¦ EU/1/09/508/003 ¦ 47895\n1 amp.-strzyk. 0,5 ml ¦ 1 igła \n05909990678082 ¦ Rp ¦ EU/1/09/508/004 ¦ 47896\n10 amp.-strzyk. 0,5 ml ¦ 10 igieł \n05909990678105 ¦ Rp ¦ EU/1/09/508/006 ¦ 47898\n1 fiol. 0,5 ml\n05909990678112 ¦ Rp ¦ EU/1/09/508/007 ¦ 47899\n10 fiol. 0,5 ml\n05909990678129 ¦ Rp ¦ EU/1/09/508/008 ¦ 47900\n100 fiol. 0,5 ml\n05909990678136 ¦ Rp ¦ EU/1/09/508/009 ¦ 47901\n100 fiol. 1 ml\nRp ¦ EU/1/09/508/010 ¦ 106110\n50 amp.-strzyk. 0,5 ml\nRp ¦ EU/0/00/000/012 ¦ 126069\n10 fiol. 2 ml\nRp ¦ EU/0/00/000/013 ¦ 126070\n100 fiol. 2 ml",
"substance": null,
"common_name": "Szczepionka przeciw pneumokokom",
"pl_product_id": "100203585",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about pneumokokken, gereinigtes polysaccharid-antigen und haemophilus influenzae b, konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.